From an analyst article: "For now, investors can remain patient and consider entering the market when prices hover between $45-$55"
Thank the board!
22 replies (most recent on top)
Every company is down. BD dropped 10% just yesterday. This is macro, I wouldn’t worry about it.
Heading to 50s by next month.
It's called a dead cat bounce for a reason...it's a bull trap. RIP to those who jumped in lmao
Exactly, investors see straight through the theatrics. Is KP not actually leaving?
Well that stock run didn’t last very long…
Dead cat bounce
Let's see how the stock recovery will last. RIFs is never good in the long run.
Stock is back on recovery now. Thankfully.
Thank the board so much!
"what you get instead if the kiss a*s bootlickers who just follow what they are told to keep their career progression intact." So much for being Bold
Our R&D doesn't just su-k because of smaller % of revenue though. There are a lot of hacks up top who have no business being R&D VPs and Directors. At that level you need to take chances and stand up for yourself and be willing to go against the grain. But what you get instead if the kiss a*s bootlickers who just follow what they are told to keep their career progression intact. No one wants to push on anything because it ki-ls their next jump and that mindset is pervasive and almost encouraged at Medtronic.
Nice day thanks for CFO who is leaving for botox lol. very fitting. Now all we need is an email GM is leaving too.
New CFO?
there are a lot of good R&D staff and leaders at MDT. used to be more. But when the company insists on putting a smaller % of revenue into R&D than any of their competitors, and preferring acquisiton fueled growth over organic, and putting good solid buisnesses into "harvest mode" to fuel Geoffs pet programs, they are fighting a loosing battle.
Could be a high estimate in 1-2 years based on current state of affairs. We’re sinking faster than OceanGate.
When Omar took over he ki-led all RD that involved two-business unit collaborations and venture programs that didn't fit squarely into any current business units, with the exception of renal, Manda, Mozarc.
The surest way to ki-l an RD project was to work between BUs. Brilliant!
@txe+1pnUXQLa Try to Have some empathy.
“R&D tech talent leaving”.. lol thanks for the laugh
We are in the mess we are in because of partially R&D as well. How many novel products has R&D developed in the last 10 years? And no, iterative design doesn’t count. This place has one of the worst managed R&D culture I have seen in my 6 years of experience. No wonder we have to pay big bucks to buyout companies and startups.
Being in operation, my 50% of my work is to deal with the mess R&D has made on our products.
Ideally all these mid level R&D VPs and Directors should be making the layoff cut
I’d cut the IT person some slack as he/she is probably affected by what’s going on over there.
Ok dude we get it, you worked in IT and the new CIO got rid of you. It su-ks. You’re posting this same theme on every thread, every topic…. But believe it or not the loss of it talent is not the biggest problem facing the company- it’s the rd tech talent leaving who build the products…. The IT problem is just another symptom of a sick company.
When MDT CIO indiscriminately laid off IT talent and outsource these to India, you are giving away your top technical talent and institutional knowledge to competitors like Boston Scientific, Abbott, JNJ for free.
It is the d-mbest decision MDT could have made, of course, it is made by a CIO who has not medical device institutional knowledge.
And she will leave in a couple of years anyway after the cuts are done. She could have cared less.
Please tell me why the MDT stock should not go down to $45? All IT technical talents go to competitors, and help competitors doing merge and acquisition, one day these competitors will by MDT in an all stock swap purchase.
Poor Earl, he would never imagine this will be happening to his great Minnesota iconic engineering company!
No. An article from a financial analyst says that those who are interested in Medtronic stock should wait to buy, or enter, when the stock reaches ~$45-$55/share. Buying now, by their prediction, is a poor idea if the buyer is interested in short-term, positive returns in value.
“Thank the board” just implies that the board of directors/leadership at this company is doing a bad job - resulting in the stock dropping in value.
Please explain this to me like I'm 12. Are you saying the board want to lower Medtronic's stock to $45?